Cited by 571Glioma Diagnosis and TreatmentCancer-related Molecular PathwaysChromatin Remodeling and Cancer

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Open access

Ishii, Nobuaki, Maier, Daniel, Merlo, Adrian, Tada, Mitsuhiro, Sawamura, Yutaka, Diserens, Annie‐Claire, Van Meir, Erwin G.·1999·Brain Pathology

DOI 10.1111/j.1750-3639.1999.tb00536.xPMC PMC8098486

Open this paper in CoChat — free account

Abstract

In this study we established the simultaneous status of TP53, p16, p14ARF and PTEN tumor suppressor genes in 34 randomly chosen human glioma cell lines. Nine cell lines (26.4%) harbored mutations or deletions in all four tumor suppressor genes and 22 cell lines (64%) had alterations in at least three. Mutations/deletions were found at the following frequencies: TP53 (76.5%), p14ARF (64.7%), p16 (64.7%), PTEN (73.5%). Thus, there was a high incidence of alterations in the cellular pathways involving the p53 transcription factor (94.1%), the retinoblastoma protein (64.7%) and the PTEN phosphatase (73.5%) and 91% of cell lines carried mutations in two or more pathways. This provides the first clear genetic evidence that these tumor suppressors participate in biological pathways which are functioning separately/independently in glioma cells. The status of the gene alterations did not correlate with tumorigenicity in immunocompromized mice or any clinical parameters. Although the mutation rate was higher in glioma cell lines than that reported for glioma tissues, the alterations were molecularly representative of those found in adult de novo glioblastoma. This study highlights the importance of developing therapeutic approaches applicable to tumors with a broad range of genetic alterations and also provides an invaluable panel of glioma cell lines to make this possible.

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.1999.tb00536.x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Self-citation
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R. E., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775

Show all 48 references

Research works printed but not linked: 1

KleihuesP CaveneeWK(1997).Pathology and Genetics of Tumors of the Nervous System.International Agency for Research on Cancer: 1st edition Lyon.

Sorted by citations

Items 501–571 of 571

MiR-21 Promotes Glioma Invasion by Targeting MMP Regulators.
Gabriely, G., Wurdinger, T. D., Kesari, S., Esau, C., Linsley, P. S., Krichevsky, A. M., Contribution, E., Neurology, D. O., Hospital, M. G., & Program, N. (2008) · Cited by 2
The Identification and Characterisation of LRIG Gene Family and Its Expression in Astrocytic Tumours
Guo, D. (2004) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Nucleolin is expressed in human fetal brain development and reactivated in human glial brain tumors regulating angiogenesis and vascular metabolismPreprint
Schwab, M., de Trizio, I., Shiu, J.-Y., Ghobrial, M., Sürücü, O., Girolamo, F., Errede, M., Yilmaz, M., Haybaeck, J., Moiraghi, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.14.337824 · Cited by 2
Targeting of TRAIL Apoptotic Pathways for Glioblastoma Therapies
Bellail, A. C., Mulligan, P., & Hao, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_41 · Cited by 2
Diamond Nanoparticles Suppress Migration of T98G Glioblastoma Cells by Targeting ECM–Integrin Interactions and Intracellular Signaling, Leading to Extensive Proteome Alterations
Zawadzka, K., Wójcik, B., Sosnowska, M., Kutwin, M., Jaworski, S., Ostrowska, A., Pruchniewski, M., & Wierzbicki, M. (2025) · Nanotechnology Science and Applications · doi:10.2147/nsa.s540050 · Cited by 1
Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin, N., Jaafar, H., Isa, M. N., & Abdullah, J. M. (2004) · PubMed · Cited by 1
Cancer Preventive and Therapeutic Properties of Fruits and Vegetables Against Commonly Occurring Cancers in Humans
Monisha, J., Padmavathi, G., Bakliwal, V., Katre, N., Padikkala, J., & Kunnumakkara, A. B. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814508896_0012 · Cited by 1
Characterization of Beryllium as a Novel Agent to Study Cell Cycle Arrest and Cellular Senescence
Gorjala, P. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/4332720 · Cited by 1
New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme
Singh, M., Jindal, D., Agarwal, V., Pathak, D., Sharma, M., Pancham, P., Mani, S., & Rachana, R. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00118 · Cited by 1
Quantification of Biologically Active DNA Alkylation in Temozolomide-Exposed Glioblastoma Cell Lines by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry: Method Development and Recommendations for Validation
Fresnais, M., Jung, I., Klein, U. B., Theile, D., Liang, S., Haefeli, W. E., Burhenne, J., & Longuespée, R. (2023) · ACS Omega · doi:10.1021/acsomega.3c01818 · Cited by 2
The contribution of proteoglycans to heterogeneity and temozolomide resistance of glioblastoma cells
Nikitina, S. A., Sokolov, D. K., Tsidulko, A. Y., Strokotova, A. V., Fasler‐Kan, E., & Витальевна, Г. Э. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.119 · Cited by 1
Avaliação da expressão imunoistoquímica da proteína p16INK4a no adenocarcinoma de esôfago
Osanai, M. H., Edelweiss, M. I. A., Meurer, L., Villwock, M. D. M., Cavazzola, L. T., Ribeiro, G., Schirmer, C. C., & Gurski, R. R. (2011) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202011000400006 · Cited by 1
Loss of p19Arf promotes fibroblast survival during leucine deprivation
Roby, K. C., Lieberman, A. E., Kim, B., Rodríguez, N. Z., Posimo, J. M., Tsang, T., Verginadis, I. I., Puré, E., Brady, D. C., Koumenis, C., et al. (2022) · Biology Open · doi:10.1242/bio.058728 · Cited by 1
Preclinical Experimental Models for Human Glioma
Zhang, D., Li, Y., Wang, Y., Jü, R., & Guo, L. (2023) · Human Brain · doi:10.37819/hb.4.1789
PI3-Kinase, PKB/Akt, mTOR, and Internal Signaling Pathways
Nakamura, J. L., & Haas-Kogan, D. A. (2006) · Elsevier eBooks · doi:10.1016/b978-012088410-0/50051-2
A combinatorial preclinical in vitro strategy against human glioblastoma cells. specific targeting of protein kinases, histone deacetylases and glycolysis
Egler, V. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005031509
Mecanismos de reparo de DNA envolvidos com lesões induzidas por agente alquilante (Nimustina) em células humanas e sua associação com a resistência de gliomas.
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
Genetic Profiling: Searching for Novel Genetic Aberrations in Glioblastoma
Jamshidi, P., & Clark, C. (2013) · InTech eBooks · doi:10.5772/53387
Gene Expression Profiling of Gliomas – Improving the Understanding of Glioma Biology and Paving the Way for Molecular Classification
Riemenschneider, M. J., & Reifenberger, G. (2008) · doi:10.1002/9783527622467.ch10
Gene expression inhibition of N-Myc downregulated gene 1 (NDRG1) monitoring and facilitation via transfectional transfer of NDRG1-siRNA constructs into- in vitro-cultured human glioblastoma cells
Said, H. M., Polat, B., Gückenberger, M., Staab, A., Hagemann, C., Anacker, J., Flentje, M. P., & Vordermark, D. (2011) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2011.6098607
Resveratrol e quercetina : avaliação da atividade antitumoral e dos mecanismos de ação em linhagens de gliomas in vitro e em um modelo de implante de gliomas in vivo
Zamin, L. L. (2010) · Americanae (AECID Library)
Frequent and variable abnormalities in p14 tumor suppressor gene in glioma cell lines
Tanaka, Y., Zhang, S., Terasaki, H., Koga, H., 遠藤, 純., Usui, H., Washiyama, K., Kumanishi, T., Uematsu, Y., & Itakura, T. (2008) · Brain Tumor Pathology · doi:10.1007/s10014-007-0226-0
Improving oncolytic viral therapy for glioma
Idema, S. (2011) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Mecanismos de indução de apoptose pela presença de danos ao DNA: um estudo sobre o papel de p53 na resistência de células de glioma a agentes quimioterápicos.
Batista, L. F. Z. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2008.tde-22092008-170922
Utilização de Análise Bioinformática e Validação por PCR Quantitativa em Tempo Real na Identificação da Indução Transcricional dos Fatores de Transcrição E2F1 e E2F4 em Linhagens de Glioblastoma.
Donaires, F. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-26092011-111938
The Radiation Induced Migration of Human Malignant Glioma Cells can be Blocked by Inhibition of the EGFR Downstream Pathways
Margraf, A. P. J. (2012) · Journal of Nuclear Medicine & Radiation Therapy · doi:10.4172/2155-9619.1000138
Human Cancer Resistance to Trail-Apoptotic Pathway-Targeted Therapies
Bellail, A. C., & Hao, C. (2013) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-1-4614-7070-0_11
Improving treatment outcomes in models of glioblastoma cancer
Verreault, M. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105090
Mecanismos de resistência à cloroquina em células de glioma humano e o uso de neurônios humanos derivados de células-tronco pluripotentes induzidas como modelo de estudo da síndrome de Cockayne
Paulo, S. (2015)
Review Article Molecular approaches to brain tumour invasion
Arnold, H., & Terzis, A. J. A. (2003)
PIK3CA,BRAF,andPTENStatusandBenefitfromCetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
Marginean, C. E., Zalcberg, J. R., Simes, J. R., Moore, M. J., Tebbutt, N. C., Price, T. J., Shapiro, J. D., Pavlakis, N., Gibbs, P., Hazel, G. A. V., et al. (2014)
In Vivo Imaging of Hypoxia Signaling Pathway in a Glioblastoma Mouse Model
Treviño, S. B. M. (2014) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010271590
The Impact of Aldehyde Dehydrogenase-1 Expression on Glioblastoma Stem Cell Capacity
Rasper, M. (2013)
Aldehyde dehydrogenase 1 A1 is expressed by cancer stem cells and mediates chemoresistance in human glioblastoma
Schäfer, A. (2012) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
MicroRNA in Human Gliomas
Conti, A., Merlo, L., La, D., & Aguennouz, M. (2011) · InTech eBooks · doi:10.5772/20172
Plexin-A2 Promotes The Proliferation And The Development Of Tumors From Glioblastoma Derived CellsPreprint
Toledano, S., Sabag, A. D., Liburkin-Dan, T., Kessler, O., & Neufeld, G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.12.452132
Searching Prognostic Hub Genes for the Management of Gliomagenesis through Transcriptome ProfilingPreprint
Murali, P., Thirunavukkarasu, M. K., Ramesh, P., Veerappapillai, S., & Karuppasamy, R. (2024) · Research Square · doi:10.21203/rs.3.rs-3915932/v1
NF-κB mediates transactivation of HNRNPD, resulting in PTEN destabilization and constitutive activation of the PI3K-AKT pathway in oral cancer cellsPreprint
Kumar, V., Mittal, A., Kumar, A., Lone, M. R., Yadav, V., Verma, P., Pradhan, D., Mishra, D., Thakar, A., & Chauhan, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.05.631360
Antiglioma activity from Aloysia virgata (Ruíz & Pavón) Juss
Schuster, M. F., Schreiner, G. E., Dartora, N., & Zamin, L. L. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100267
Additional file 1 of Characterization and comparison of human glioblastoma models
Schulz, J., Rodgers, L. T., Kryscio, R. J., Hartz, A. M. S., & Bauer, B. (2022) · Figshare · doi:10.6084/m9.figshare.20430653
Additional file 3 of Characterization and comparison of human glioblastoma models
Schulz, J., Rodgers, L. T., Kryscio, R. J., Hartz, A. M. S., & Bauer, B. (2022) · Figshare · doi:10.6084/m9.figshare.20430659
Additional file 14 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692219
Additional file 3 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692186
Additional file 6 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692195
Additional file 2 of Characterization and comparison of human glioblastoma models
Schulz, J., Rodgers, L. T., Kryscio, R. J., Hartz, A. M. S., & Bauer, B. (2022) · Figshare · doi:10.6084/m9.figshare.20430656
Additional file 4 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692189
Additional file 13 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692216
Additional file 9 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692204
Additional file 1 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397550
Additional file 8 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692201
Additional file 10 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692207
Additional file 12 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692213
Additional file 11 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692210
Additional file 5 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692192
Additional file 2 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397682
Additional file 1 of Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas
Wolter, M., Felsberg, J., Malzkorn, B., Kaulich, K., & Reifenberger, G. (2022) · Figshare · doi:10.6084/m9.figshare.19497898
Additional file 7 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Walter, B., Hirsch, S., Kuhlburger, L., Stahl, A., Schnabel, L., Wisser, S., Haeusser, L. A., Tsiami, F., Plöger, S., Aghaallaei, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692198
Involvement of neuropilin-1 in radiation-induced cell death via modulation of DNA double-strand break repair in glioblastoma T98G cells
Tsutsumi, K., Kawahara, K., Kojima, M., Yuasa, A., IMAZATO, M., KIDACHI, J., Yamamoto, N., & Nakano, H. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130906
Caractérisation de l'axe intégrine α5β1/protéine p53 dans les gliobastomes humains : application à une thérapie ciblée anti-tumorale
Renner, G. (2016) · theses.fr (ABES) · doi:10.70675/deb4fa44ze885z42b5zbaf7zdb798d1b1b3a
Identification des mécanismes moléculaires et cellulaires sous jacents à la perte de Pten dans l’épithélium prostatique murin et étude du rôle de la Vitamine D dans la carcinogenèse prostatique
Grelet, É. (2018) · theses.fr (ABES) · doi:10.70675/acc680a1zecfdz4c85z8f27z1fd05d90a500
Ophiobolin A Induces an Apoptotic Transcriptional Signature and Modulates Redox Homeostasis in T98G and U118MG Glioblastoma Cells: A Machine Learning Approach
Woźnicki, P., Hudy, D., Trzaskoś, O., Avijit, P., Xavierselvan, M., Tabarkiewicz, J., Strzelczyk, J. K., & Aebisher, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156891
High-Throughput Discovery of Near-Infrared Oxazine Probes for Fluorescence-Guided Glioblastoma Surgery
Cataldi, V., Tailor, D., Montaño, A. R., Rizvi, S. Z. H., Chakraborty, S., Saldivar, J. C., Malhotra, S. V., Wang, L. G., Gibbs, S. L., & Alani, A. W. G. (2026) · Cancers · doi:10.3390/cancers18162684
Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma
Rivera-Caraballo, K., Vázquez-Arreguín, K., Singh, H., Sahu, U., Kaur, M., Jahan, E., Hong, B., Sharma, A., & Kaur, B. (2026) · Oncogene · doi:10.1038/s41388-026-03985-5
Cytokine-induced killer cells combined with temozolomide suppress glioblastoma progression in an orthotopic model and demonstrate clinical feasibility in recurrent glioblastoma
Park, Y. K., Yang, D. W., Park, K. W., Nam, G. H., Lee, C.-S., Kim, T. W., Kim, J.-Y., & Choi, J. G. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1895857
Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells
Grávalos-Cano, I., Morales‐Ruíz, T., Ariza, R. R., Roldán‐Arjona, T., & Martínez-Macías, M. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27208941
Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1 , Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models
Zhao, K., Meyer, L., Braun, M., Otte, K., Bitter, C., Pawlik, M., Raifer, H., Helmprobst, F., Pagenstecher, A., Urban, H., et al. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70357
BindingDB Entry 3566: Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.
BindingDB (2011) · UC San Diego · doi:10.7270/q2np22s9
BindingDB Entry 50004570: Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.
BindingDB (2020) · UC San Diego · doi:10.7270/q2125wh0
BindingDB Entry 50004674: Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.
BindingDB (2020) · UC San Diego · doi:10.7270/q2q52sgd
Platelet-derived growth factor receptor alpha overexpression cooperates with ink4a/arf loss to promote gliomagenesis---roles of shp-2 and pi3k pathways
Liu, K.-W. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Glioma chemotherapy sensitization mediated by base excision repair inhibition and its potential application
Tang, J.-B. (2010) · D-Scholarship@Pitt (University of Pittsburgh)

Authors: Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
University Hospital of Basel (CH)
Hokkaido University (JP)
ORCID: Ishii, Nobuaki
Tada, Mitsuhiro
Venue: Brain Pathology
Publisher: Wiley
Published: 1999-07
Volume: 9
Issue: 3
Pages: 469-479
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/j.1750-3639.1999.tb00536.x
PMC: PMC8098486
OpenAlex: W2155140015
Cited by: 569
References: 48
Citations by year: 2026: 9 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 23 · 2020: 13 · 2019: 25 · 2018: 14 · 2017: 16 · 2016: 14 · 2015: 27 · 2014: 33 · 2013: 25 · 2012: 34
FWCI: 11.06
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2470 d)
Locations: Brain Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: glioma cell lines, TP53 mutation, CDKN2A/p16, p14ARF, PTEN, p53 pathway, glioblastoma, tumorigenicity, genetic alterations
MeSH terms: Adult, Aged, Animals, Brain Neoplasms, Child, DNA Mutational Analysis, Female, Glioma, Humans, Male, Mice, Nude, Middle Aged, Neoplasm Transplantation, Neoplastic Processes, Phosphoric Monoester Hydrolases, Proteins, Sex Factors, Tumor Cells, Cultured, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Point Mutation, Sequence Deletion, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Tumor Suppressor Protein p14ARF, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks